Related Experiment Video
Updated: Sep 29, 2025

Modeling Myotonic Dystrophy 1 in C2C12 Myoblast Cells
Published on: July 29, 2016
Complement C1q Binding Protein (C1QBP): Physiological Functions, Mutation-Associated Mitochondrial Cardiomyopathy and
Jie Wang1,2,3,4, Christopher L-H Huang5, Yanmin Zhang1,2,3,4,6
1National Regional Children's Medical Center (Northwest), Xi'an, China.
Complement C1q binding protein (C1QBP) deficiency causes mitochondrial disorders. Mutations in C1QBP are linked to inherited oxidative phosphorylation issues, affecting multiple organ systems and presenting diverse clinical symptoms.
Area of Science:
- Biochemistry
- Genetics
- Mitochondrial Biology
Background:
- Complement C1q binding protein (C1QBP, p32) is crucial for mitochondrial oxidative phosphorylation.
- C1QBP deficiency results in multi-system mitochondrial disorders.
- Recent studies link C1QBP mutations to autosomal recessive combined oxidative phosphorylation deficiency.
Purpose of the Study:
- To review the physiological roles of C1QBP.
- To summarize C1QBP mutation-associated mitochondrial cardiomyopathy in patients.
- To discuss current experimental models for these conditions.
Main Methods:
- Literature review of C1QBP function.
- Analysis of clinical data from patients with C1QBP mutations.
- Evaluation of existing disease modeling platforms.
Main Results:
- C1QBP is vital for mitochondrial function.
- C1QBP mutations lead to a spectrum of mitochondrial diseases.
- Clinical manifestations include intrauterine growth restriction, cardiomyopathy, and ophthalmoplegia.
Conclusions:
- C1QBP plays a critical role in mitochondrial health.
- Understanding C1QBP mutations is key to diagnosing and treating mitochondrial disorders.
- Experimental models are essential for further research into C1QBP-related diseases.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
ATP Synthase: Mechanism
Mitochondrial Precursor Proteins
Most of the mitochondrial...
Cardiomyopathy II: Dilated Cardiomyopathy
Complement System

